Paulex Bio Inc., 2025-12-18
An SEC Form D private-offering notice from La Jolla, CA, a $22,500,000 filer-stated offering target in Biotech. Filed 2025-12-18. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Paulex Bio develops an oral regenerative medicine designed to restore insulin producing beta cells to treat type 1 and type 2 diabetes.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- NEONC TECHNOLOGIES HOLDINGS, INC., 2025-12-18, $1M, Calabasas, CA
- Voyage Foods Inc., 2025-12-18, $45M, Oakland, CA
- Ceretype Neuromedicine, Inc., 2025-12-18, $400K, Cambridge, MA
- HUMAN AI LABS, INC., 2025-12-18, $23.1M, San Francisco, CA
- InSitu Biologics, Inc, 2025-12-18, $8M, Oakdale, MN
- Delfi Diagnostics, Inc., 2025-12-18, $60M, Palo Alto, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.